More recently, an increase in SOD2 and CAT mRNA and protein levels in fibroblasts of SCA2 patients relative to controls was found, highlighting the significance of these enzymes in counteracting SCA2 neurodegenerative processes (24). The gene discussed is SOD2; the disease is spinocerebellar ataxia type 2.